Follow this preprint
SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies
Dami A. Collier, Anna De Marco, Isabella A.T.M. Ferreira, Bo Meng, Rawlings Datir, View ORCID ProfileAlexandra C. Walls, Steven A. Kemp S, Jessica Bassi, View ORCID ProfileDora Pinto, Chiara Silacci Fregni, Siro Bianchi, View ORCID ProfileM. Alejandra Tortorici, John Bowen, View ORCID ProfileKatja Culap, View ORCID ProfileStefano Jaconi, View ORCID ProfileElisabetta Cameroni, Gyorgy Snell, Matteo S. Pizzuto, View ORCID ProfileAlessandra Franzetti Pellanda, Christian Garzoni, View ORCID ProfileAgostino Riva, The CITIID-NIHR BioResource COVID-19 Collaboration, Anne Elmer, Nathalie Kingston, Barbara Graves, View ORCID ProfileLaura E McCoy, Kenneth GC Smith, John R. Bradley, Nigel Temperton, Lourdes Ceron-Gutierrez L, Gabriela Barcenas-Morales, The COVID-19 Genomics UK (COG-UK) consortium, William Harvey, View ORCID ProfileHerbert W. Virgin, View ORCID ProfileAntonio Lanzavecchia, View ORCID ProfileLuca Piccoli, Rainer Doffinger, Mark Wills, View ORCID ProfileDavid Veesler, View ORCID ProfileDavide Corti, View ORCID ProfileRavindra K. Gupta
doi: https://doi.org/10.1101/2021.01.19.21249840
Now published in Nature doi: 10.1038/s41586-021-03412-7
Dami A. Collier
1Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
2Department of Medicine, University of Cambridge, Cambridge, UK
3Division of Infection and Immunity, University College London, London, UK
Anna De Marco
4Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Isabella A.T.M. Ferreira
1Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
2Department of Medicine, University of Cambridge, Cambridge, UK
Bo Meng
1Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
2Department of Medicine, University of Cambridge, Cambridge, UK
Rawlings Datir
1Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
2Department of Medicine, University of Cambridge, Cambridge, UK
3Division of Infection and Immunity, University College London, London, UK
Alexandra C. Walls
5Department of Biochemistry, University of Washington, Seattle, WA 98195, USA
Steven A. Kemp S
1Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
2Department of Medicine, University of Cambridge, Cambridge, UK
3Division of Infection and Immunity, University College London, London, UK
Jessica Bassi
4Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Dora Pinto
4Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Chiara Silacci Fregni
4Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Siro Bianchi
4Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
M. Alejandra Tortorici
5Department of Biochemistry, University of Washington, Seattle, WA 98195, USA
John Bowen
5Department of Biochemistry, University of Washington, Seattle, WA 98195, USA
Katja Culap
4Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Stefano Jaconi
4Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Elisabetta Cameroni
4Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Gyorgy Snell
6Vir Biotechnology, San Francisco, CA 94158, USA
Matteo S. Pizzuto
4Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Alessandra Franzetti Pellanda
7Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, Switzerland
Christian Garzoni
7Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, Switzerland
Agostino Riva
8Division of Infectious Diseases, Luigi Sacco Hospital, University of Milan, Milan, Italy
Anne Elmer
10NIHR Cambridge Clinical Research Facility, Cambridge, UK
Nathalie Kingston
11NIHR Bioresource, Cambridge, UK
Barbara Graves
11NIHR Bioresource, Cambridge, UK
Laura E McCoy
3Division of Infection and Immunity, University College London, London, UK
Kenneth GC Smith
1Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
2Department of Medicine, University of Cambridge, Cambridge, UK
John R. Bradley
2Department of Medicine, University of Cambridge, Cambridge, UK
11NIHR Bioresource, Cambridge, UK
Nigel Temperton
12University of Kent, Canturbury, UK
Lourdes Ceron-Gutierrez L
13Department of Clinical Biochemistry and Immunology, Addenbrookes Hospital, UK
Gabriela Barcenas-Morales
13Department of Clinical Biochemistry and Immunology, Addenbrookes Hospital, UK
14Laboratorio de Inmunologia, S-Cuautitlán, UNAM, Mexico
William Harvey
16Institute of Biodiversity, University of Glasgow, Glasgow, UK
Herbert W. Virgin
6Vir Biotechnology, San Francisco, CA 94158, USA
Antonio Lanzavecchia
4Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Luca Piccoli
4Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Rainer Doffinger
13Department of Clinical Biochemistry and Immunology, Addenbrookes Hospital, UK
Mark Wills
2Department of Medicine, University of Cambridge, Cambridge, UK
David Veesler
5Department of Biochemistry, University of Washington, Seattle, WA 98195, USA
Davide Corti
4Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Ravindra K. Gupta
1Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
2Department of Medicine, University of Cambridge, Cambridge, UK
17University of KwaZulu Natal, Durban, South Africa
18Africa Health Research Institute, Durban, South Africa
19Department of Infectious Diseases, Cambridge University Hospitals NHS Trust, Cambridge UK
Data Availability
Data are available from the corresponding author on request
Posted February 15, 2021.
SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies
Dami A. Collier, Anna De Marco, Isabella A.T.M. Ferreira, Bo Meng, Rawlings Datir, Alexandra C. Walls, Steven A. Kemp S, Jessica Bassi, Dora Pinto, Chiara Silacci Fregni, Siro Bianchi, M. Alejandra Tortorici, John Bowen, Katja Culap, Stefano Jaconi, Elisabetta Cameroni, Gyorgy Snell, Matteo S. Pizzuto, Alessandra Franzetti Pellanda, Christian Garzoni, Agostino Riva, The CITIID-NIHR BioResource COVID-19 Collaboration, Anne Elmer, Nathalie Kingston, Barbara Graves, Laura E McCoy, Kenneth GC Smith, John R. Bradley, Nigel Temperton, Lourdes Ceron-Gutierrez L, Gabriela Barcenas-Morales, The COVID-19 Genomics UK (COG-UK) consortium, William Harvey, Herbert W. Virgin, Antonio Lanzavecchia, Luca Piccoli, Rainer Doffinger, Mark Wills, David Veesler, Davide Corti, Ravindra K. Gupta
medRxiv 2021.01.19.21249840; doi: https://doi.org/10.1101/2021.01.19.21249840
Now published in Nature doi: 10.1038/s41586-021-03412-7
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
50
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (418)
- Allergy and Immunology (740)
- Anesthesia (217)
- Cardiovascular Medicine (3180)
- Dermatology (268)
- Emergency Medicine (469)
- Epidemiology (13156)
- Forensic Medicine (18)
- Gastroenterology (879)
- Genetic and Genomic Medicine (4988)
- Geriatric Medicine (458)
- Health Economics (764)
- Health Informatics (3143)
- Health Policy (1115)
- Hematology (418)
- HIV/AIDS (988)
- Medical Education (463)
- Medical Ethics (122)
- Nephrology (512)
- Neurology (4736)
- Nursing (252)
- Nutrition (701)
- Oncology (2437)
- Ophthalmology (692)
- Orthopedics (272)
- Otolaryngology (335)
- Pain Medicine (316)
- Palliative Medicine (88)
- Pathology (524)
- Pediatrics (1265)
- Primary Care Research (539)
- Public and Global Health (7301)
- Radiology and Imaging (1641)
- Respiratory Medicine (954)
- Rheumatology (468)
- Sports Medicine (411)
- Surgery (528)
- Toxicology (66)
- Transplantation (226)
- Urology (196)